Sana Biotechnology (SANA) Change in Acquisitions & Divestments (2020 - 2026)
Sana Biotechnology recorded quarterly Change in Acquisitions & Divestments of $55.1 million in Q1 2026, up 178.11% quarter-over-quarter from $19.8 million in Q4 2025, and up 203.09% year-over-year from $18.2 million in Q1 2025.
Sana Biotechnology's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $55.1 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments rose 203.09% year-over-year to $55.1 million; the TTM figure through Mar 2026 stood at $83.5 million (down 65.53% YoY), while the FY2025 annual figure was $46.6 million, down 83.19% from the prior year.
- Change in Acquisitions & Divestments came in at $55.1 million for Q1 2026 at Sana Biotechnology, up from $19.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $113.9 million in Q3 2023 to a low of $1.4 million in Q3 2025.
- A 5-year average of $61.1 million and a median of $55.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments soared 727.67% in 2022 and tumbled 98.28% in 2025, its largest moves.
- Sana Biotechnology's Change in Acquisitions & Divestments stood at $108.1 million in 2022, then slumped by 48.69% to $55.5 million in 2023, then advanced by 9.22% to $60.6 million in 2024, then plunged by 67.33% to $19.8 million in 2025, then soared by 178.11% to $55.1 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $55.1 million, $19.8 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.07 Mn |
| Mar 31, 2026 | 55.07 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Dec 31, 2025 | 19.80 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.41 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Jun 30, 2025 | 7.19 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Mar 31, 2025 | 18.17 Mn |
| Dec 31, 2024 | 60.60 Mn |
| Dec 31, 2024 | 60.60 Mn |
| Sep 30, 2024 | 81.84 Mn |
| Sep 30, 2024 | 81.84 Mn |
| Jun 30, 2024 | 81.50 Mn |
| Jun 30, 2024 | 81.50 Mn |
| Mar 31, 2024 | 53.01 Mn |
| Mar 31, 2024 | 53.01 Mn |
| Dec 31, 2023 | 55.48 Mn |
| Dec 31, 2023 | 55.48 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | 95.04 Mn |
| Jun 30, 2023 | 95.04 Mn |
| Mar 31, 2023 | 85.33 Mn |
| Mar 31, 2023 | 85.33 Mn |
| Dec 31, 2022 | 108.14 Mn |
| Dec 31, 2022 | 108.14 Mn |
| Sep 30, 2022 | 53.83 Mn |
| Sep 30, 2022 | 53.83 Mn |
| Jun 30, 2022 | 102.41 Mn |
| Jun 30, 2022 | 102.41 Mn |
| Mar 31, 2022 | 45.75 Mn |
| Mar 31, 2022 | 45.75 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Sep 30, 2021 | 71.05 Mn |
| Sep 30, 2021 | 71.05 Mn |
| Jun 30, 2021 | 95.57 Mn |
| Jun 30, 2021 | 95.57 Mn |
| Mar 31, 2021 | 100.34 Mn |
| Mar 31, 2021 | 100.34 Mn |
| Dec 31, 2020 | 102.34 Mn |
| Dec 31, 2020 | 102.34 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Jun 30, 2020 | 9.34 Mn |
| Jun 30, 2020 | 9.34 Mn |
| Mar 31, 2020 | 44.78 Mn |
| Mar 31, 2020 | 44.78 Mn |